MiVu™, only from Diversatek Healthcare, detects esophageal mucosal changes due to chronic GERD and EoE, and as importantly, MiVu provides objective evidence of no inflammatory disease. Detection is instant during routine endoscopy, potentially obviating the need for 24- to 48-hour ambulatory pH monitoring or esophageal biopsies for histopathology, reducing both diagnostic and treatment latency.